Paragraph 5 Form of the documents contained in the pharmacovigilance system master fileF1
The pharmacovigilance system master file documents must be complete and legible.
Subject to sub-paragraph (1), in the pharmacovigilance system master file—
where appropriate, information may be provided in the form of charts or flow diagrams;
all documents must be indexed and archived so as to ensure their accurate and ready retrieval throughout the period for record-keeping; and
the particulars and documents may be presented in modules in accordance with the system delineated in detail in the guidance on good pharmacovigilance practices which applies by virtue of regulation 205B.
The pharmacovigilance system master file may be stored in electronic form provided that the media used for storage remain readable over time, and a clearly arranged printed copy can be made available for audits and inspections.
Annotations
Textual amendments
- F1
Sch. 12A inserted (31.12.2020) by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 (S.I. 2019/775), reg. 1, Sch. 6 (as amended by S.I. 2019/1385, reg. 1, Sch. 1 para. 9 and S.I. 2020/1488, reg. 1, Sch. 2 para. 192); 2020 c. 1, Sch. 5 para. 1(1)